Monday, December 13, 2010

Status quo

About half-way through the second cycle of crizotinib. Pretty much just status quo. No new side effects. Nothing new to measure progress. A little more than a week until I get a CT and will have more definitive information regarding the progress of the test/study drug.

No comments: